Renalytix plc Deferred Tax Assets, Valuation Allowance
Renalytix plc (RENXF) had Deferred Tax Assets, Valuation Allowance of $55.44 million as of 2024-06-30, per its 10-K filed 2024-09-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2024-09-30
- 2024-06-30: Deferred Tax Assets, Valuation Allowance $55.44M.
- 2023-06-30: Deferred Tax Assets, Valuation Allowance $45.60M.
- 2022-06-30: Deferred Tax Assets, Valuation Allowance $31.11M.
- 2021-06-30: Deferred Tax Assets, Valuation Allowance $21.05M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2024-06-30 | $55.44M 10-K · filed 2024-09-30 |
| 2023-06-30 | $45.60M 10-K · filed 2024-09-30 |
| 2022-06-30 | $31.11M 10-K · filed 2023-09-28 |
| 2021-06-30 | $21.05M 20-F · filed 2022-10-31 |
| 2020-06-30 | $7.33M 20-F · filed 2022-10-31 |
| 2019-06-30 | $5.00M 20-F/A · filed 2022-08-01 |
| 2018-06-30 | $166.00K 20-F/A · filed 2020-11-10 |